Raras
Buscar doenças, sintomas, genes...
Cistinúria
ORPHA:214CID-10 · E72.0CID-11 · 5C60.2OMIM 220100DOENÇA RARA

Cistinúria é uma condição que afeta o transporte de aminoácidos nos túbulos dos rins e se caracteriza pela formação repetida de pedras de cistina nos rins.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Cistinúria é uma condição que afeta o transporte de aminoácidos nos túbulos dos rins e se caracteriza pela formação repetida de pedras de cistina nos rins.

Pesquisas ativas
6 ensaios
24 total registrados no ClinicalTrials.gov
Publicações científicas
1.526 artigos
Último publicado: 2026 Feb
Medicamentos
1 registrados
DAPAGLIFLOZIN

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
DAPAGLIFLOZIN

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
40.0
Specific population
Início
All ages
🏥
SUS: Cobertura mínimaScore: 20%
Triagem neonatal (Fase 2)CID-10: E72.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (7)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)nutritional
0301070040
Atendimento em reabilitação — doenças raras
+1 outros procedimentos
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
5 sintomas
🫃
Digestivo
2 sintomas
📏
Crescimento
1 sintomas

+ 13 sintomas em outras categorias

Características mais comuns

90%prev.
Cistinúria
Muito frequente (99-80%)
90%prev.
Anormalidade do metabolismo de aminoácidos
Muito frequente (99-80%)
90%prev.
Nefrolitíase
Muito frequente (99-80%)
90%prev.
Hematúria
Muito frequente (99-80%)
55%prev.
Odor urinário anormal
Frequente (79-30%)
55%prev.
Hipertensão
Frequente (79-30%)
21sintomas
Muito frequente (4)
Frequente (8)
Ocasional (3)
Sem dados (6)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 21 características clínicas mais associadas, ordenadas por frequência.

CistinúriaCystinuria
Muito frequente (99-80%)90%
Anormalidade do metabolismo de aminoácidosAbnormality of amino acid metabolism
Muito frequente (99-80%)90%
NefrolitíaseNephrolithiasis
Muito frequente (99-80%)90%
HematúriaHematuria
Muito frequente (99-80%)90%
Odor urinário anormalAbnormal urinary odor
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.526PubMed
Últimos 10 anos200publicações
Pico202343 papers
Linha do tempo
2026Hoje · 2026🧪 1998Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: MS/MS (espectrometria de massas em tandem)
Fase 2 do PNTNin_rollout
Incidência no Brasil: 1:10.000 (coletivo)

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive, Semi-dominant.

SLC7A9b(0,+)-type amino acid transporter 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Associates with SLC3A1 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1:1 (PubMed:16825196, PubMed:32494597, PubMed:32817565, PubMed:8663357). Has system b(0,+)-like activity with high affinity for extracellular cationic amino acids and L-cystine and lower affinity for intracellular neutral amino acids (PubMed:16825196, PubMed:32494597, PubMed:8663357). Substrate exchange is driven by

LOCALIZAÇÃO

Apical cell membraneCell membrane

VIAS BIOLÓGICAS (3)
Basigin interactionsAmino acid transport across the plasma membraneDefective SLC3A1 causes cystinuria (CSNU)
MECANISMO DE DOENÇA

Cystinuria

An autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
44.8 TPM
Rim - Córtex
11.1 TPM
Fígado
7.1 TPM
Rim - Medula
3.3 TPM
Cerebelo
2.1 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cystinuriacystinuria type B
HGNC:11067UniProt:P82251
SLC3A1Amino acid transporter heavy chain SLC3A1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a chaperone that facilitates biogenesis and trafficking of functional transporter heteromers to the plasma membrane (By similarity) (PubMed:10588648, PubMed:11318953, PubMed:16609684, PubMed:16825196, PubMed:32494597, PubMed:32817565, PubMed:7686906, PubMed:8486766, PubMed:8663184, PubMed:8663357). Associates with SLC7A9 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1:1. SLC7A

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Amino acid transport across the plasma membraneDefective SLC7A9 causes cystinuria (CSNU)
MECANISMO DE DOENÇA

Cystinuria

An autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
29.4 TPM
Rim - Medula
18.3 TPM
Intestino delgado
14.8 TPM
Pâncreas
13.7 TPM
Cólon transverso
2.2 TPM
OUTRAS DOENÇAS (5)
cystinuriacystinuria type Ahypotonia-cystinuria syndrome2p21 microdeletion syndrome
HGNC:11025UniProt:Q07837

Medicamentos e terapias

DAPAGLIFLOZINPhase 2

Mecanismo: Sodium/glucose cotransporter 2 inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

385 variantes patogênicas registradas no ClinVar.

🧬 SLC3A1: NM_000341.4(SLC3A1):c.1655_1656del (p.Tyr552fs) ()
🧬 SLC3A1: GRCh38/hg38 2p21(chr2:44277851-44353363)x1 ()
🧬 SLC3A1: NM_000341.4(SLC3A1):c.988C>T (p.Gln330Ter) ()
🧬 SLC3A1: NM_000341.4(SLC3A1):c.2019C>A (p.Cys673Ter) ()
🧬 SLC3A1: NM_000341.4(SLC3A1):c.1972C>T (p.Arg658Cys) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 734 variantes classificadas pelo ClinVar.

110
110
514
Patogênica (15.0%)
VUS (15.0%)
Benigna (70.0%)
VARIANTES MAIS SIGNIFICATIVAS
PREPL: NM_000341.4(SLC3A1):c.1655_1656del (p.Tyr552fs) [Pathogenic]
SLC3A1: NM_000341.4(SLC3A1):c.988C>T (p.Gln330Ter) [Pathogenic]
PREPL: NM_000341.4(SLC3A1):c.2019C>A (p.Cys673Ter) [Pathogenic]
SLC3A1: NM_000341.4(SLC3A1):c.892-3T>G [Uncertain significance]
SLC3A1: NM_000341.4(SLC3A1):c.710A>G (p.Tyr237Cys) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 32
2Fase 26
·Pré-clínico12
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Cistinúria

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

24 ensaios clínicos encontrados, 6 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
365 papers (10 anos)
#1

Comparative analysis of surgical costs vs. theoretical tiopronin therapy in pediatric cystinuria: a single-center experience from Türkiye.

The Turkish journal of pediatrics2026 Feb 27

Cystinuria is a rare autosomal recessive disorder leading to recurrent cystine stone formation, often necessitating repeated surgical interventions. In Türkiye, tiopronin-a proven medical therapy-has become inaccessible since 2019, raising concerns about its economic and clinical consequences. This study aimed to compare the annual hospital costs of surgical management with the theoretical cost of tiopronin therapy in pediatric cystinuria patients. This single-center, retrospective study included 10 consecutive pediatric patients (median age: 12 years; range: 3-17 years) with genetically or biochemically confirmed cystinuria who underwent surgery for cystine stones in 2023. The annual cost of surgical management was calculated by summing all direct medical costs (operating room, anesthesia, devices, hospitalization, and related diagnostics) obtained from the hospital billing database. The theoretical annual cost of tiopronin therapy was calculated based on the last accessible market price of the drug in Türkiye, converted to Turkish Lira at the 2023 average exchange rate, and adjusted per patient using a standard dosing regimen of 15 mg/kg/day. Costs were compared using the Mann-Whitney U test. The median annual surgical cost per patient was 49,936 TL (range: 14,791-84,576 TL), compared to a theoretical tiopronin cost of 27,923 TL (range: 9,307-27,925 TL). Surgical management was significantly more expensive than tiopronin therapy (p=0.001) in 9 of 10 cases. Six patients had a history of tiopronin use, and five of them experienced a surgery-free interval during medication (median duration: 3 years; range: 2-6 years). Preliminary follow-up data for 2024 revealed that 70% of patients required further surgical interventions (median: 2 surgeries per patient), demonstrating the persistent and recurrent nature of the disease when managed solely with surgery. Surgical treatment of cystinuria poses a substantially higher economic burden compared to tiopronin therapy. Our findings support the reintroduction of tiopronin into the Turkish healthcare system, particularly for pediatric patients with frequent stone recurrence.

#2

Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic SLC34A3 and Monoallelic SLC3A1 Pathogenic Variants: Who is 'The Culprit'?

Kidney &amp; blood pressure research2026 Mar 18

Kidney stones are common and can arise from many etiologies including genetic and environmental. Biallelic pathogenic variants in the solute carrier family 34-member 3 (SLC34A3) gene cause Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH), while both monallaelic and biallelic pathogenic variants in SLC3A1 cause cystinuria. Here, we report the clinical phenotype of a patient with concomitant biallelic and monoallelic pathogenic variants in SLC34A3 and SLC3A1 respectively.

#3

Cystinuria in an Australian Cattle Dog Family-A Seemingly Androgen-Associated Autosomal Dominant Trait.

Veterinary sciences2026 Jan 22

In Australian Cattle Dogs (AUCDs), cystinuria was reported to be an autosomal dominant trait caused by a 6 bp deletion in the SLC3A1 gene (type II-A). Here we report an androgen association in this breed. A family of 11 adult AUCDs (five intact and one neutered male and five females) was genotyped for the SLC3A1 c.1095_1100del variant, and urine was examined for concentrations of cystine, ornithine, lysine, and arginine (COLA). Among this family, three males and five females tested heterozygous for the mutation, while all other AUCDs were homozygous for the wild-type allele. The two heterozygous intact males had severe COLA-uria, which decreased markedly after castration. Neither the third heterozygous male with a history of cystine calculi but already castrated nor the five heterozygous females exhibited increased COLA-uria. Heterozygosity for the 6 bp deletion in the SLC3A1 gene was associated with cystinuria in intact male AUCDs, but not in females. Castration of the heterozygous males reduced the cystinuria. Either the type II-A cystinuria in the AUCDs is an androgen-associated dominant trait, or this family also has another type III (androgen-dependent) cystinuria. Larger surveys are needed to further define the type(s) of cystinuria and effects of castration in AUCDs.

#4

Unexpected genotypes associated with severe paediatric conditions identified in a healthy population cohort.

European journal of human genetics : EJHG2026 Mar

The expansion of genomics provides opportunity to screen individuals beyond clinical indication yet the classification of genomic variants and implications for health outcomes in this context is still emerging. We investigated this further by analysing clinically relevant variants and expected clinical implications in a population with no reported medical conditions. Whole genomes from 9637 healthy unrelated research-consented participants in Singapore were analysed focusing on 1619 genes associated with severe paediatric disease. Association between causative variants and expected phenotype was assessed in correlation with participant characteristics and medical history where available. After considering protein impact, mode of inheritance and participant demographics for 110 variants, further analysis was performed for 44 variants occurring in 150 participants to understand clinical implications. Most carried variants associated with a mild phenotype (cystinuria), late onset (Fabry disease) or a potentially missed phenotype (Hajdu-Cheney syndrome). However, nine participants had variants associated with severe paediatric disease predicted to be symptomatic, such as limb-girdle muscular dystrophy and spastic paraplegia. Despite a cohort selected for absence of pre-existing health conditions, individuals were identified carrying variants associated with severe paediatric conditions. Further work is required to examine for subtle clinical symptoms or alternate genetic suppression mechanisms. This study revealed the challenge of predicting clinical outcomes from genotype-derived screening and emphasises the importance of expanding phenotype characterisation which is highly relevant in population and reproductive screening settings. Trial registration: NCT02791152.

#5

L-Ergothioneine Attenuates Nephrolithiasis by Modulating Redox Signaling and Mitochondrial Function in Cystine and Calcium Oxalate Models.

Antioxidants &amp; redox signaling2026 Mar 11

Nephrolithiasis is a major global health challenge, with oxidative stress and mitochondrial dysfunction emerging as key drivers of renal injury and stone formation. l-ergothioneine (l-Erg), a naturally occurring antioxidant transported by OCTN1, has shown promising effects in cystinuria models, preventing stone formation. Despite evidence supporting an indirect mechanism of action, key mechanistic aspects have yet to be fully clarified. This study aimed to evaluate whether l-Erg can prevent stone progression in cystinuria and in other types of lithiasis, such as calcium oxalate nephrolithiasis, and to further elucidate its mechanistic basis. Using mouse models, l-Erg significantly reduced cystine stone growth and renal inflammation, and its combination with d-penicillamine enhanced stone dissolution and mitigated drug-related toxicity. In calcium oxalate nephrolithiasis, l-Erg decreased crystal deposition, preserved renal architecture, normalized glutathione levels, and restored mitochondrial respiration. Transcriptomic analysis revealed downregulation of immune pathways and activation of cell cycle genes, suggesting attenuation of inflammation and promotion of tubular repair. This study is the first to demonstrate that l-Erg exerts renoprotective effects through combined antioxidant and mitochondrial mechanisms in two major forms of nephrolithiasis and introduces a dual therapeutic approach combining an antioxidant with a cystine-solubilizing agent. By targeting oxidative stress and mitochondrial dysfunction, l-Erg represents a promising therapeutic strategy for nephrolithiasis, either alone or as an adjunct to current treatments. Antioxid. Redox Signal. 00, 000-000.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC956 artigos no totalmostrando 195

2026

Comparative analysis of surgical costs vs. theoretical tiopronin therapy in pediatric cystinuria: a single-center experience from Türkiye.

The Turkish journal of pediatrics
2026

Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic SLC34A3 and Monoallelic SLC3A1 Pathogenic Variants: Who is 'The Culprit'?

Kidney &amp; blood pressure research
2025

Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits.

Frontiers in medicine
2026

L-Ergothioneine Attenuates Nephrolithiasis by Modulating Redox Signaling and Mitochondrial Function in Cystine and Calcium Oxalate Models.

Antioxidants &amp; redox signaling
2026

Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone disease.

The Journal of clinical investigation
2026

Synergistic Effects in a Homochiral Metal-Organic Framework Enable Enhanced Enantiomeric Discrimination and Ultrasensitive Detection of Disulfide-Containing Biomarkers.

ACS sensors
2026

A novel ratiometric fluorescent sensing strategy of arginine based on lanthanide-based metal-organic framework.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2026

Cystinuria in an Australian Cattle Dog Family-A Seemingly Androgen-Associated Autosomal Dominant Trait.

Veterinary sciences
2026

Unexpected genotypes associated with severe paediatric conditions identified in a healthy population cohort.

European journal of human genetics : EJHG
2025

Acquired cystinuria in a kidney transplant recipient.

Clinical kidney journal
2026

Colorimetric "off-on" sensing of penicillamine via copper-mediated modulation of laccase-mimetic activity of trimanganese tetroxide nanoflowers.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2025

Dietary salt and protein intake and urinary cystine excretion in patients with cystinuria.

Clinical kidney journal
2026

Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review.

Pediatric nephrology (Berlin, Germany)
2026

Differential clinical characteristics of Chinese children with primary hyperoxaluria type 3.

Pediatric nephrology (Berlin, Germany)
2025

Nephrotic Syndrome Induced by Tiopronin in a Male Patient with Cystinuria.

Balkan journal of medical genetics : BJMG
2025

Whole-exome sequencing of kidney transplant recipients and donors: insights into end-stage renal disease and post-transplant genetic risk.

BMC nephrology
2025

Mechanisms involved in aminoacidurias: impacts of genetic and environmental factors.

Current research in physiology
2025

Genetic and clinical characteristics of Japanese cystinuria with exon and exon-intron boundary variants.

Scientific reports
2025

Oxalate stones in a cystinuria patient.

Nefrologia
2025

Urinary Cystine/Creatinine Concentrations Before and After Castration in Dogs With Suspected Androgen-Dependent Cystine Urolithiasis.

Journal of veterinary internal medicine
2025

Outcomes of Tiopronin and D-Penicillamine Therapy in Pediatric Cystinuria: A Clinical Comparison of Two Cases.

Reports (MDPI)
2025

Whole Exome Sequencing in Chinese Pediatric Patients With Nephrolithiasis.

Kidney international reports
2025

Partial correction of cystinuria type A in mice via kidney-targeted transposon delivery.

Molecular therapy. Nucleic acids
2025

A Case of Cystinuria With Compound Heterozygous Mutations Both in SLC3A1 and SLC7A9 Genes.

Electrolyte &amp; blood pressure : E &amp; BP
2025

Management of urinary stones by experts in stone disease (ESD 2025).

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
2025

Dual-mode colorimetric and fluorometric detection of D-penicillamine via inhibition of peroxidase-mimetic activity of bimetallic N-doped carbon dots.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2025

Cystinuria: a genetic and molecular view. What is known about animal models and cells.

Kidney &amp; blood pressure research
2025

Kidney stones and metabolic bone diseases not linked to parathyroid disfunction: a proposal for an integrated management.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
2025

Disruptions in Tiopronin therapy: impacts on clinical outcomes of pediatric cystinuria patients during the COVID-19 pandemic.

Urolithiasis
2025

Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience.

Genes
2025

Sex and Age Variation for Nephrolithiasis Risk Factors on 24-Hour Urine Metabolic Evaluation: A Real-World Single-center Retrospective Analysis.

Urology
2025

Understanding Rare Kidney Stone Diseases: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

Enhancing Renal Stone Management: Tip-Flexible Ureteral Access Sheath in Cystine Stone Surgery.

The American journal of case reports
2025

Epidemiological Evaluation of Neuter Status, Sex, and Breed in Dogs With Cystine Uroliths.

Journal of veterinary internal medicine
2025

Cystinuria in children: diagnosis and treatment.

World journal of urology
2025

Comprehensive analysis of pediatric urolithiasis in a tertiary care center and insights into demographics, risk factors, and management outcomes.

Journal of pediatric urology
2025

Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel.

Urolithiasis
2025

Mitochondrial SLC3A1 regulates sexual dimorphism in cystinuria.

Genes &amp; diseases
2025

Exploring tiopronin adsorption on pristine and Al/Ga-doped boron nitride nanoclusters: A DFT approach for enhanced drug delivery.

Journal of molecular graphics &amp; modelling
2025

Cystinuria-Related Urinary Stone as the Cause of Repeated Urinary Tract Infections (UTIs) in a Child.

Cureus
2025

Kidney Stones in Children: Causes, Consequences, and Concerns.

Indian pediatrics
2024

The Impact of Stone Composition on Treatment Strategies for Patients with Urolithiasis: A Narrative Review.

Cureus
2024

Characteristics and Yield of Modern Approaches for the Diagnosis of Genetic Causes of Kidney Stone Disease.

Genes
2024

The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria.

Urolithiasis
2024

Discovery of l-Lysine Dioxalate (LH1513) as a Novel Inhibitor of Calcium Oxalate Crystallization for Hyperoxaluria.

ACS medicinal chemistry letters
2024

A narrative review of monogenic disorders causing nephrolithiasis and chronic kidney disease.

Nephrology (Carlton, Vic.)
2024

Structure-activity relationships and pharmacokinetic evaluation of L-cystine diamides as L-cystine crystallization inhibitors for cystinuria.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
2024

Cystine crystal nucleation and decay in the context of cystinuria pathogenesis and treatment.

RSC advances
2024

Challenges in diagnosis and treatment of cystinuria patients with Urolithiasis: multicenter patient centered study.

World journal of urology
2024

Cystine urolithiasis-free duration after first occurrence and treatment is longer for castrated dogs than for sexually intact male dogs.

Journal of the American Veterinary Medical Association
2025

The role of double heterozygotes of SLC3A1 and SLC7A9 in the prevalence of cystine stones.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Tiopronin-induced Membranous Nephropathy Presenting with IgG4-predominant Staining Pattern.

Internal medicine (Tokyo, Japan)
2024

Transient Urinothorax Following Nephrostomy Tube Placement and Percutaneous Nephrolithotomy: A Case Report.

Cureus
2024

8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria.

ACS medicinal chemistry letters
2024

Prenatal diagnosis of cystinuria with a heterozygous pathogenic variant in SLC7A9 gene associated with isolated hyperechogenic fetal kidneys: A case report.

Clinical case reports
2024

The Yield of Genetic Testing in Management of Nephrolithiasis.

Urology
2025

Bone mineral density assessment in patients with cystinuria.

Journal of nephrology
2024

Covalent post-synthetic modification of MOFs as a fluorescent sensor for the efficient detection of the biomarker of cystinuria.

Mikrochimica acta
2024

Management of urinary stones: state of the art and future perspectives by experts in stone disease.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
2024

Adeno-associated virus-based gene therapy for cystinuria.

BJU international
2024

Recurrent symptomatic urolithiasis in a patient with cystic fibrosis.

Pediatric nephrology (Berlin, Germany)
2024

Ureteroscopic management in cystinuric patients: long-term results from a tertiary care referral center.

World journal of urology
2024

Unilateral renal mucormycosis in a patient presenting with pyelonephritis and acute kidney failure: A case report.

Clinical case reports
2024

Genome editing and kidney health.

Clinical kidney journal
2024

Renal Cystinuria and Immune Cells (T Lymphocytes) Dysfunction: What We Know about?

Nephron
2024

Review of childhood genetic nephrolithiasis and nephrocalcinosis.

Frontiers in genetics
2024

Prevalence and characteristics of genetic disease in adult kidney stone formers.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024

Donor-transmitted cystinuria in a renal transplant recipient.

Journal of nephrology
2024

Effect of urine alkalization on urinary inflammatory markers in cystinuric patients.

Clinical kidney journal
2024

Cystinuria Complicated by Anuria From Bilateral Obstructing Stones Requiring Bilateral Mini Percutaneous Nephrolithotomy in a 22-Month-Old.

Urology
2024

A RETROSPECTIVE STUDY OF DISEASE PROCESSES IN MANED WOLVES (CHRYSOCYON BRACHYURUS) IN NORTH AMERICAN ZOOLOGICAL INSTITUTIONS WITH EMPHASIS ON UROLITHIASIS, INFLAMMATORY BOWEL DISEASE, AND NEOPLASIA.

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
2024

The genetics of cystinuria - an update and critical reevaluation.

Current opinion in nephrology and hypertension
2023

Exploring the Contribution of the Transporter AGT1/rBAT in Cystinuria Progression: Insights from Mouse Models and a Retrospective Cohort Study.

International journal of molecular sciences
2023

Novel compound heterozygous pathogenic variants in the SLC3A1 gene in a Chinese family with cystinuria.

BMC medical genomics
2023

Thiazide Use for the Prevention of Recurrent Calcium Kidney Stones.

Clinical journal of the American Society of Nephrology : CJASN
2023

Hydration for Adult Patients with Nephrolithiasis: Specificities and Current Recommendations.

Nutrients
2024

Postnatal outcome of children with antenatal colonic hyperechogenicity.

Prenatal diagnosis
2023

A retrospective study on epidemiology and management of canine cystine uroliths in one part of Norway from 2015 to 2020.

Acta veterinaria Scandinavica
2024

Pharmacological interventions for the management of cystinuria: a systematic review.

Journal of nephrology
2023

A case of hyperlysinemia identified by urine newborn screening.

JIMD reports
2023

2022 Recommendations of the AFU Lithiasis Committee: Medical management - from diagnosis to treatment.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
2023

Clinical Course and Mutational Analysis of Patients with Cystine Stone: A Single-Center Experience.

Biomedicines
2023

Molecular identification of missense variants in SLC3A1 gene; an approach leading to computer-aided drug design for cystinuria.

Gene
2023

Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
2023

The effectiveness of citrates and pyridoxine in the treatment of kidney stones.

Journal of medicine and life
2023

Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections.

ACS applied materials &amp; interfaces
2023

An amperometric method for the determination of cystine in urine samples and pharmaceutical tablets using screen-printed silver electrodes.

Journal of pharmaceutical and biomedical analysis
2023

A new case of Melnick-Needles syndrome with skeletal manifestations: A case report.

International journal of surgery case reports
2023

Population genetics analysis of SLC3A1 and SLC7A9 revealed the etiology of cystine stone may be more than what our current genetic knowledge can explain.

Urolithiasis
2023

Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report.

BMC urology
2023

Realization of Amyloid-like Aggregation as a Common Cause for Pathogenesis in Diseases.

Life (Basel, Switzerland)
2023

Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability.

Urolithiasis
2023

The antioxidant l-Ergothioneine prevents cystine lithiasis in the Slc7a9-/- mouse model of cystinuria.

Redox biology
2023

Self-Assembly of Cysteine into Nanofibrils Precedes Cystine Crystal Formation: Implications for Aggregation Inhibition.

ACS applied materials &amp; interfaces
2023

Cystine Stones: Developments in Minimally Invasive Surgery and Their Impact on Morbidity and Stone Clearance.

Research and reports in urology
2023

Cystinuria without cystine? Correct assessment to avoid misdiagnosis: lessons for the clinical nephrologist.

Journal of nephrology
2023

Research progress on renal calculus associate with inborn error of metabolism.

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2023

Thulium fiber laser in cystine calculi.

International braz j urol : official journal of the Brazilian Society of Urology
2023

Rapid detection of the biomarker for cystinuria by a metal-organic framework fluorescent sensor.

Talanta
2023

Why is childhood urolithiasis increasing? Etiology, diagnosis and management: a single-center experience.

Journal of nephrology
2023

Use of whole-exome sequencing to identify novel monogenic gene mutations and genotype-phenotype correlations in Chinese Han children with urolithiasis.

Frontiers in genetics
2023

Typical course of cystinuria leading to untypical complications in pregnancy: A case report and review of literature.

Frontiers in medicine
2023

Entering into 2.0 cystinuric management with a medical digital tool to monitor urine pH: a prospective, randomized study.

Actas urologicas espanolas
2023

Unraveling the natural history of presymptomatic cystinuria.

Current opinion in nephrology and hypertension
2023

Cystinuria, an Atypical Presentation and Challenges of Establishing its Diagnosis in a Poor Resource Set Up.

Journal of Nepal Health Research Council
2023

Evaluation of the value of genetic testing for cystinuria in the Danish population of English bulldogs.

Animal genetics
2023

A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria.

Healthcare (Basel, Switzerland)
2022

Diagnosis and Management of Nephrolithiasis in Children.

Pediatric clinics of North America
2023

Pediatric cystine stone successfully treated by mini-percutaneous nephrolithotripsy and antegrade ureteroscopy.

IJU case reports
2023

Hydration and Nephrolithiasis in Pediatric Populations: Specificities and Current Recommendations.

Nutrients
2023

Urinary stone disease in Syrian children.

Pediatric nephrology (Berlin, Germany)
2022

Genetic and clinical analysis of Chinese pediatric patients with cystinuria.

Urolithiasis
2023

Case-based review of dietary management of cystinuria.

World journal of urology
2023

Penicillamine-induced degenerative dermopathy in a patient with Wilson's disease.

The Australasian journal of dermatology
2022

Can prenatal renal pelvicalyceal echogenic foci support the diagnosis of cystinuria?

Journal of the Turkish German Gynecological Association
2023

Antenatal Hyperechogenic Colon and Cystinuria.

Clinical pediatrics
2022

Clinical Characteristics and In Silico Analysis of Cystinuria Caused by a Novel SLC3A1 Mutation.

Genes
2023

Pediatric urolithiasis: what can pediatricians expect from radiologists?

Pediatric radiology
2023

Service evaluation of a clinical scientist-led cystinuria clinic.

Annals of clinical biochemistry
2022

Knotted double j ureteral stent: a case report and literature review.

The Pan African medical journal
2023

Phenotypic characterization of a pediatric cohort with cystinuria and usefulness of newborn screening.

Pediatric nephrology (Berlin, Germany)
2022

Monogenic urinary lithiasis in Tunisian children: 25 years' experience of a referral center.

La Tunisie medicale
2022

Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.

Urolithiasis
2022

A pediatric case of ureterolithiasis due to cystinuria accompanied by acute appendicitis; a case report.

International journal of surgery case reports
2022

Young Adults With Hereditary Tubular Diseases: Practical Aspects for Adult-Focused Colleagues.

Advances in chronic kidney disease
2022

Tiopronin-induced membranous nephropathy in a patient with refractory familial cystinuria.

British journal of hospital medicine (London, England : 2005)
2022

A mouse model of type B cystinuria due to spontaneous mutation in FVB/NJcl mice.

Urolithiasis
2022

Systematic assessment of monogenic etiology in adult-onset kidney stone formers undergoing urological intervention-evidence for genetic pretest probability.

American journal of medical genetics. Part C, Seminars in medical genetics
2022

Cystinuria: An Overview of Diagnosis and Medical Management.

Turkish archives of pediatrics
2022

Metabolic and Genetic Evaluation in Children with Nephrolithiasis.

Indian journal of pediatrics
2022

Novel "Turn-On" Luminescent Chemosensor for Arginine by Using a Lanthanide Metal-Organic Framework Photosensitizer.

Analytical chemistry
2022

Cystinuria: An Overview of Challenges and Surgical Management.

Frontiers in surgery
2022

Comprehensive proteomic quantification of bladder stone progression in a cystinuric mouse model using data-independent acquisitions.

PloS one
2022

Coexistence of Megaconial Congenital Muscular Dystrophy and Cystinuria: Mimicking Hypotonia-Cystinuria Syndrome.

Molecular syndromology
2022

Lipidomics characterization of the lipid metabolism profiles in a cystinuria rat model: Precalculus damage in the kidney of cystinuria.

Prostaglandins &amp; other lipid mediators
2022

Ca2+-mediated higher-order assembly of heterodimers in amino acid transport system b0,+ biogenesis and cystinuria.

Nature communications
2022

Differences in renal cortex transcriptional profiling of wild-type and novel type B cystinuria model rats.

Urolithiasis
2023

Repurposing of Various Current Medicines as Radioprotective Agents.

Anti-cancer agents in medicinal chemistry
2022

Concomitant Urinary Triple Phosphate and Cystine Crystals.

The New England journal of medicine
2022

Crystalline structures of L-cysteine and L-cystine: a combined theoretical and experimental characterization.

Amino acids
2022

Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.

JIMD reports
2021

Hyperechoic Content of the Fetal Colon Is Not Always Cystinuria-Case Report.

Frontiers in pediatrics
2022

Progressive dermopathy akin to pseudoxanthoma elasticum after D-penicillamine use in a patient with cystinuria.

Rheumatology (Oxford, England)
2021

Comparison of Renal Stones and Nephrocalcinosis in Children: Findings From Two Tertiary Centers in Saudi Arabia.

Frontiers in pediatrics
2022

Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention.

Accounts of chemical research
2022

Can cystinuria decrease the effectiveness of RIRS with high-power ho:yag laser in children? Outcomes from a tertiary endourology referral center.

Urolithiasis
2022

Childhood nephrolithiasis and nephrocalcinosis caused by metabolic diseases and renal tubulopathy: A retrospective study from 2 tertiary centers.

Saudi medical journal
2022

Gene therapy for kidney disease: targeting cystinuria.

Current opinion in nephrology and hypertension
2021

Cystinuria: Review of a Life-long and Frustrating Disease.

The Yale journal of biology and medicine
2021

Extracorporeal Shockwave Lithotripsy for Cystine Stones in Children: An Observational, Retrospective, Single-Center Analysis.

Frontiers in pediatrics
2021

Development of a Novel Benzimidazole-Based Probe and Portable Fluorimeter for the Detection of Cysteine in Human Urine.

Biosensors
2022

Cystinuria: an update on pathophysiology, genetics, and clinical management.

Pediatric nephrology (Berlin, Germany)
2021

A Novel Variant in Iranian Patient with Cystinuria: A Case Report.

Iranian journal of public health
2021

The Ectodomains of rBAT and 4F2hc Are Fake or Orphan α-Glucosidases.

Molecules (Basel, Switzerland)
2022

A case of early onset cystinuria in a 4-month-old girl.

CEN case reports
2021

Distinction of chiral penicillamine using metal-ion coupled cyclodextrin complex as chiral selector by trapped ion mobility-mass spectrometry and a structure investigation of the complexes.

Analytica chimica acta
2021

Hypotonia-cystinuria 2p21 deletion syndrome: Intrafamilial variability of clinical expression.

Annals of clinical and translational neurology
2021

S-Methyl-L-Ergothioneine to L-Ergothioneine Ratio in Urine Is a Marker of Cystine Lithiasis in a Cystinuria Mouse Model.

Antioxidants (Basel, Switzerland)
2021

Atomistic Assessment of Cystine Kidney Stone Behavior in a Mechanical Breakdown Process by Nanobiorobots through Classical Molecular Dynamics Simulations.

The journal of physical chemistry. B
2021

Cystinuria in Dogs and Cats: What Do We Know after Almost 200 Years?

Animals : an open access journal from MDPI
2021

Unusual Aggregates Formed by the Self-Assembly of Proline, Hydroxyproline, and Lysine.

ACS chemical neuroscience
2021

The zebrafish cationic amino acid transporter/glycoprotein-associated family: sequence and spatiotemporal distribution during development of the transport system b0,+ (slc3a1/slc7a9).

Fish physiology and biochemistry
2021

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system.

Expert opinion on drug safety
2021

Milestones in treatments for inborn errors of metabolism: Reflections on Where chemistry and medicine meet.

American journal of medical genetics. Part A
2021

Extremely rapid stone formation in cystinuria: look out for dietary supplements!

Clinical kidney journal
2021

Bariatric surgery in a patient with cystinuria.

Clinical nephrology. Case studies
2021

Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) detection as a rapid and convenient screening test for cystinuria.

Clinica chimica acta; international journal of clinical chemistry
2021

Cystinuria poorly responding to treatment - the risk of chronic kidney disease.

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
2021

Analysis of SLC7A9 gene mutations among Jordanian patients with cystinuria.

Annals of medicine and surgery (2012)
2021

Outcome of primary tubular tubulopathies diagnosed in pediatric age.

Nefrologia
2021

The Impact of Diet on Urinary Risk Factors for Cystine Stone Formation.

Nutrients
2021

An Update on Evaluation and Management in Cystinuria.

Urology
2020

[A complicated case of calcium urolithiasis in a carrier of SLC7A9 gene mutation responsible for cystinuria].

Urologiia (Moscow, Russia : 1999)
2021

Clinical profile of a Polish cohort of children and young adults with cystinuria.

Renal failure
2021

Outcomes of dissolution therapy and monitoring for stone disease: should we do better?

Current opinion in urology
2020

[Evaluation and perspective of 20 years of neonatal screening in Galicia. Program results.].

Revista espanola de salud publica
2020

Diversity of Phenotype and Genetic Etiology of 23 Cystinuria Saudi Patients: A Retrospective Study.

Frontiers in pediatrics
2021

Urolithiasis/Endourology.

The Journal of urology
2021

Efficacy of transurethral cystolithotripsy assisted by percutaneous evacuation and the benefit of genetic analysis in a pediatric cystinuria patient with a large bladder stone.

Urology case reports
2021

Non-contrast computed tomography characteristics in a large cohort of cystinuria patients.

World journal of urology
2020

Metal-organic frameworks: a future toolbox for biomedicine?

Chemical Society reviews
2020

WITHDRAWN: Clinical characteristics of pediatric patients with cystinuria at the Puigvert Foundation in the last 20 years.

Actas urologicas espanolas
2021

Integration of exome sequencing and metabolic evaluation for the diagnosis of children with urolithiasis.

World journal of urology
2021

Cystinuria: clinical practice recommendation.

Kidney international
2020

Endourologic and Retroperitoneoscopic Combined Mininvasive Management of Cystine Urolithiasis in an Infant of 13 Months of Life.

Journal of endourology case reports
2021

Metabolic and Clinical Characteristics of Children with Urolithiasis from Southern India.

Indian journal of pediatrics
2020

Pharmacological Dilutional Therapy Using the Vasopressin Antagonist Tolvaptan for Young Patients With Cystinuria: A Pilot Investigation.

Urology
2021

Computational analysis identifies druggable mutations in human rBAT mediated Cystinuria.

Journal of biomolecular structure &amp; dynamics
2020

[Molecular and genetic technologies for the diagnosis of monogenic forms of urinary stone disease: clinical cases].

Urologiia (Moscow, Russia : 1999)
2020

Re: CRISPR/Cas9 Engineering of Albino Cystinuria Type A Mice.

The Journal of urology
2020

Genetics of kidney stone disease.

Nature reviews. Urology
2020

Update on cystine stones: current and future concepts in treatment.

Intractable &amp; rare diseases research
2020

Elastosis perforans serpiginosa induced by d-penicillamine treated with cyclosporine and allopurinol.

Dermatologic therapy
2020

Cystinuria: urine sediment as a diagnostic test.

Advances in laboratory medicine
2020

The Use of Captopril-Angiotensin Converting Enzyme (ACE) Inhibitor for Cystinuria During COVID-19 Pandemic.

Urology
Ver todos os 956 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Cistinúria.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Cistinúria

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Comparative analysis of surgical costs vs. theoretical tiopronin therapy in pediatric cystinuria: a single-center experience from T&#xfc;rkiye.
    The Turkish journal of pediatrics· 2026· PMID 41871560mais citado
  2. Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic SLC34A3 and Monoallelic SLC3A1 Pathogenic Variants: Who is 'The Culprit'?
    Kidney &amp; blood pressure research· 2026· PMID 41849633mais citado
  3. Cystinuria in an Australian Cattle Dog Family-A Seemingly Androgen-Associated Autosomal Dominant Trait.
    Veterinary sciences· 2026· PMID 41600767mais citado
  4. Unexpected genotypes associated with severe paediatric conditions identified in a healthy population cohort.
    European journal of human genetics : EJHG· 2026· PMID 41520097mais citado
  5. L-Ergothioneine Attenuates Nephrolithiasis by Modulating Redox Signaling and Mitochondrial Function in Cystine and Calcium Oxalate Models.
    Antioxidants &amp; redox signaling· 2026· PMID 41814506mais citado
  6. Bilateral Life-Threatening Obstructive Cystine Stones in a 19-Month-Old Child Requiring Staged Endourological Management: A Case Report.
    Cureus· 2026· PMID 41909285recente
  7. Coexisting genetic kidney disease explains many cases of 'familial' IgA nephropathy where the proband has biopsy-confirmed mesangial IgA deposits.
    Front Med (Lausanne)· 2025· PMID 41847665recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:214(Orphanet)
  2. OMIM OMIM:220100(OMIM)
  3. MONDO:0009067(MONDO)
  4. GARD:6237(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q1149046(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Cistinúria
Compêndio · Raras BR

Cistinúria

ORPHA:214 · MONDO:0009067
🇧🇷 Brasil SUS
Triagem
MS/MS (espectrometria de massas em tandem)
PNTN
Fase 2
Incidência BR
1:10.000 (coletivo)
Geral
Prevalência
1-5 / 10 000
Herança
Autosomal recessive, Semi-dominant
CID-10
E72.0 · Distúrbios do transporte de aminoácidos
CID-11
Ensaios
6 ativos
Medicamentos
1 registrados
Início
All ages
Prevalência
40.0 (Specific population)
MedGen
UMLS
C0010691
Repurposing
1 candidato
penicillamine-(D)chelating agent
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades